Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans.

Lithium interaction with adenylate cyclase signalling system.

Inhibition by lithium of dopamine-sensitive adenylate-cyclase in the rat brain.

Inhibition of adenylate cyclase by tetraplatin.

Inhibition of adenylate cyclase by polyadenylate.

Combined effect of lithium and flupenthixol on striatal adenylate cyclase.

Letter: Lithium and the adenylate cyclase-cAMP system.

Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.

Effect on platelet activity of inhibition of adenylate cyclase.

Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase.

Inhibition of adenylate cyclase by hormones and neurotransmitters.

Inhibition of gonadotropin sensitive adenylate cyclase by ovarian follicular fluid.

Inhibition of platelet adenylate cyclase by epinephrine requires GTP.

Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.

alpha-adrenoceptor mediated inhibition of human fat cell adenylate cyclase.

Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. I. Inhibition by heparin of gonadotrophin-stimulated ovarian adenylate cyclase.

Inhibition of human liver membrane adenylate cyclase by zinc ions.

Inhibition of adenylate cyclase by p-bromophenacyl bromide.

Frustration and adenylate cyclase.

Renal adenylate cyclase systems.

The effect of haloperidol on epinephrine-stimulated adenylate cyclase in humans.

Adenylate cyclase-centred microdomains.

$Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of non-nuclear adenylate cyclase.$
Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of non-nuclear adenylate cyclase.

$Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of a nuclear adenylate cyclase.$
Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of a nuclear adenylate cyclase.

Reevaluation of adenylate cyclase in Reissner's membrane.

Suggest Documents

Lithium interaction with adenylate cyclase signalling system.

Inhibition by lithium of dopamine-sensitive adenylate-cyclase in the rat brain.

Inhibition of adenylate cyclase by tetraplatin.

Inhibition of adenylate cyclase by polyadenylate.

Combined effect of lithium and flupenthixol on striatal adenylate cyclase.

Letter: Lithium and the adenylate cyclase-cAMP system.

Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.

Effect on platelet activity of inhibition of adenylate cyclase.

Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase.

Inhibition of adenylate cyclase by hormones and neurotransmitters.

Inhibition of gonadotropin sensitive adenylate cyclase by ovarian follicular fluid.

Inhibition of platelet adenylate cyclase by epinephrine requires GTP.

Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.

alpha-adrenoceptor mediated inhibition of human fat cell adenylate cyclase.

Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. I. Inhibition by heparin of gonadotrophin-stimulated ovarian adenylate cyclase.

Inhibition of human liver membrane adenylate cyclase by zinc ions.

Inhibition of adenylate cyclase by p-bromophenacyl bromide.

Frustration and adenylate cyclase.

Renal adenylate cyclase systems.

The effect of haloperidol on epinephrine-stimulated adenylate cyclase in humans.

Adenylate cyclase-centred microdomains.

Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of non-nuclear adenylate cyclase.

Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of a nuclear adenylate cyclase.

Reevaluation of adenylate cyclase in Reissner's membrane.

Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans.

Recommend Documents

Follow Us